Unknown

Dataset Information

0

Manassantin A inhibits tumour growth under hypoxia through the activation of chaperone-mediated autophagy by modulating Hsp90 activity


ABSTRACT: Background: Chaperon-mediated autophagy (CMA) has taken on a new emphasis in cancer biology. However, the roles of CMA in hypoxic tumours are poorly understood. We investigated the anti-tumour effects of the natural product ManA through the activation of CMA in tumour progression under hypoxia. Methods: The effect of ManA on CMA activation was assessed in mouse xenograft models and cells. The gene expressions of HIF-1α, HSP90AA1, and transcription factor EB (TFEB) were analysed using The Cancer Genome Atlas (TCGA) datasets to assess the clinical relevance of CMA. Results: ManA activates photoswitchable CMA reporter activity and inhibits Hsp90 chaperone function by disrupting the Hsp90/F1F0-ATP synthase complex. Hsp90 inhibition enhances the interaction between CMA substrates and LAMP-2A and TFEB nuclear localisation, suggesting CMA activation by ManA. ManA-activated CMA retards tumour growth and displays cooperative anti-tumour activity with anti-PD-1 antibody. TCGA datasets show that a combined expression of HSP90AA1High/HIF1AHigh or TFEBLow/HIF1AHigh is strongly correlated with poor prognosis in patients with lung cancer. Conclusions: ManA-induced CMA activation by modulating Hsp90 under hypoxia induces HIF-1α degradation and reduces tumour growth. Thus, inducing CMA activity by targeting Hsp90 may be a promising therapeutic strategy against hypoxic tumours.

ORGANISM(S): Homo sapiens

PROVIDER: GSE110768 | GEO | 2024/01/22

REPOSITORIES: GEO

Similar Datasets

2020-07-02 | PXD016630 | Pride
2015-07-24 | E-GEOD-55212 | biostudies-arrayexpress
2015-07-24 | E-GEOD-59729 | biostudies-arrayexpress
2018-12-25 | GSE83988 | GEO
2023-04-01 | GSE221264 | GEO
2022-11-15 | GSE200207 | GEO
2015-07-24 | GSE55212 | GEO
2015-07-24 | GSE59729 | GEO
2014-05-14 | E-GEOD-55915 | biostudies-arrayexpress
2023-11-15 | GSE244260 | GEO